Application of AP1M2 gene as molecular marker for glaucoma diagnosis

• Main Author: LI CHENGFANG
• Format: Patent
• Language: Chinese; English
• Published: 28.12.2018
• Subjects: BEER; BIOCHEMISTRY; CHEMISTRY; COMPOSITIONS OR TEST PAPERS THEREFOR; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES; ENZYMOLOGY; INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES; MEASURING; MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS; METALLURGY; MICROBIOLOGY; MUTATION OR GENETIC ENGINEERING; PHYSICS; PROCESSES OF PREPARING SUCH COMPOSITIONS; SPIRITS; TESTING; VINEGAR; WINE

The invention discloses an application of an AP1M2 gene for preparation of a diagnosis product. The diagnosis product can be applied to glaucoma diagnosis. Whether a subject suffers from glaucoma or the risk of the subject who will suffer from glaucoma in the future can be judged by detection of expression level of the AP1M2 gene. With the adoption of the diagnosis product, rapid, sensitive and accurate diagnosis effect can be realized. 本发明公开了AP1M2基因在制备诊断产品中的应用。该诊断产品可用于青光眼的诊断。通过检测AP1M2基因表达水平可以判断受试者是否患有青光眼或者将来患有青光眼的风险大小。本发明的诊断产品可实现快速、灵敏和准确的诊断效果。